Who pays for this conference? It’s time patients and doctors knewBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g3748 (Published 11 June 2014) Cite this as: BMJ 2014;348:g3748
- Paolo Vercellini, associate professor of obstetrics and gynaecology1,
- Paola Viganò, in vitro fertilisation laboratory director2,
- Edgardo Somigliana, director, infertility unit3
- 1Department of Obstetrics and Gynaecology, Università degli Studi and Fondazione Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy.
- 2Department of Obstetrics and Gynaecology, San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy
- 3Fondazione Ca’ Granda Ospedale Maggiore Policlinico, Via Manfredo Fanti 6, 20122, Milan, Italy
McCartney notes that patients do not know whether their doctors are chosen key opinion leaders who are paid by a drug company to increase prescribing of a drug, or whether their doctors’ travel to international conferences was paid for by the drug company that makes the product that is being recommended to them.1
Because of the potential effect on speakers and audience, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial